Wo finden aktuell Insiderkäufe statt?
Die folgende Übersicht zeigt die Summe der Aktienkäufe & -verkäufe von Insidern am offenen Markt. Sonstige Zuteilungen bspw. als Gehaltsbestandteil wurden bereits rausgefiltert.
USA
Unternehmen | Anz. Insider | Vol. Käufe | Vol. Verkäufe | Differenz |
---|---|---|---|---|
ARTV | 5 | 164.999.952 $ | 0 $ | 164.999.952 $ |
Alumis | 3 | 120.000.000 $ | 0 $ | 120.000.000 $ |
Appian | 1 | 58.700.246 $ | 0 $ | 58.700.246 $ |
PDCC | 1 | 58.361.701 $ | 0 $ | 58.361.701 $ |
Archer Aviation | 1 | 54.999.824 $ | 0 $ | 54.999.824 $ |
Eliem Therapeutics | 2 | 49.952.817 $ | 3.446.685 $ | 46.506.132 $ |
Noble | 1 | 42.161.987 $ | 0 $ | 42.161.987 $ |
VCRDX | 1 | 25.000.000 $ | 0 $ | 25.000.000 $ |
PBF Energy | 1 | 20.990.019 $ | 0 $ | 20.990.019 $ |
MorningStar Partners | 2 | 19.560.000 $ | 0 $ | 19.560.000 $ |
Neurobo Pharmaceuticals | 1 | 17.964.382 $ | 0 $ | 17.964.382 $ |
TWFG | 9 | 17.406.929 $ | 0 $ | 17.406.929 $ |
Alpha Teknova | 3 | 15.149.998 $ | 0 $ | 15.149.998 $ |
Tamboran Resources | 8 | 13.951.052 $ | 0 $ | 13.951.052 $ |
Blackrock Innovation & Growth Trust | 1 | 13.732.932 $ | 0 $ | 13.732.932 $ |
Citi Trends | 2 | 11.408.456 $ | 0 $ | 11.408.456 $ |
LGF | 1 | 11.232.811 $ | 0 $ | 11.232.811 $ |
RH | 1 | 9.999.977 $ | 0 $ | 9.999.977 $ |
DiaMedica Therapeutics | 2 | 6.000.000 $ | 0 $ | 6.000.000 $ |
VETZ | 1 | 5.009.960 $ | 0 $ | 5.009.960 $ |
DMA | 1 | 4.267.036 $ | 0 $ | 4.267.036 $ |
Adams Natural Resources Closed Fund | 1 | 3.976.348 $ | 0 $ | 3.976.348 $ |
Rekor Systems | 1 | 3.185.000 $ | 0 $ | 3.185.000 $ |
ClearSign Combustion | 1 | 3.048.500 $ | 0 $ | 3.048.500 $ |
Taysha Gene Therapies Inc | 1 | 2.999.999 $ | 0 $ | 2.999.999 $ |
Tile Shop Holdings | 1 | 2.882.362 $ | 0 $ | 2.882.362 $ |
American Software | 2 | 2.766.015 $ | 0 $ | 2.766.015 $ |
Tillys | 3 | 2.735.143 $ | 135.858 $ | 2.599.285 $ |
Truist Financial | 1 | 2.518.908 $ | 0 $ | 2.518.908 $ |
Sunrise Realty Trust | 5 | 2.514.553 $ | 0 $ | 2.514.553 $ |
Aclaris Therapeutics | 1 | 2.349.777 $ | 0 $ | 2.349.777 $ |
ADC Therapeutics | 1 | 2.248.000 $ | 0 $ | 2.248.000 $ |
REFLX | 1 | 2.205.000 $ | 0 $ | 2.205.000 $ |
LB | 3 | 2.198.525 $ | 0 $ | 2.198.525 $ |
ARCA Biopharma | 1 | 2.126.509 $ | 0 $ | 2.126.509 $ |
Atlas Energy Solutions | 2 | 1.991.744 $ | 170.477 $ | 1.821.267 $ |
Adverum Biotechnologies | 1 | 1.785.662 $ | 0 $ | 1.785.662 $ |
Barnes & Noble Education | 3 | 1.685.450 $ | 0 $ | 1.685.450 $ |
Charles Schwab | 4 | 2.276.954 $ | 616.135 $ | 1.660.819 $ |
Allied Gaming & Entertainment | 1 | 1.542.523 $ | 0 $ | 1.542.523 $ |
Nuzee | 2 | 1.540.911 $ | 0 $ | 1.540.911 $ |
Pioneer Municipal High Income Advantage Trust | 1 | 1.518.765 $ | 0 $ | 1.518.765 $ |
STRATA Skin Sciences | 3 | 1.507.972 $ | 0 $ | 1.507.972 $ |
Wag! Group Co. | 2 | 1.465.800 $ | 17.541 $ | 1.448.259 $ |
Alta Equipment Group | 1 | 1.444.444 $ | 0 $ | 1.444.444 $ |
New York City REIT | 1 | 1.389.755 $ | 0 $ | 1.389.755 $ |
CPSI | 1 | 1.252.464 $ | 0 $ | 1.252.464 $ |
Ipsidy | 2 | 1.224.993 $ | 0 $ | 1.224.993 $ |
AASP | 2 | 1.187.340 $ | 0 $ | 1.187.340 $ |
GAB.N | 1 | 1.175.000 $ | 0 $ | 1.175.000 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung!